John P Headrick Selected Research

1,3-dipropyl-8-cyclopentylxanthine

1/2007	Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine.
7/2005	Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine.
7/2002	Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John P Headrick Research Topics

Disease

32	Ischemia 09/2020 - 01/2002
6	Inflammation (Inflammations) 01/2021 - 05/2011
5	Insulin Resistance 01/2022 - 01/2016
5	Body Weight (Weight, Body) 01/2022 - 05/2018
5	Obesity 01/2021 - 03/2013
5	Infarction (Infarctions) 01/2017 - 07/2005
5	Contracture 12/2007 - 01/2002
4	Myocardial Ischemia (Ischemic Heart Diseases) 06/2021 - 10/2002
4	Reperfusion Injury 01/2018 - 05/2002
3	Type 2 Diabetes Mellitus (MODY) 09/2020 - 12/2019
3	Necrosis 12/2007 - 02/2003
2	Heart Failure 01/2021 - 01/2017
2	Weight Gain 01/2020 - 12/2019
2	Cardiomyopathies (Cardiomyopathy) 12/2017 - 01/2017
2	Hypoxia (Hypoxemia) 11/2013 - 05/2002
2	Ischemic Contracture 01/2012 - 02/2005
1	Diabetes Mellitus 01/2021
1	Disease Progression 01/2021
1	Chronic Renal Insufficiency 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Death (Near-Death Experience) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Anhedonia 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2019
1	Glucose Intolerance 12/2019
1	Myocardial Infarction 05/2018
1	Gilbert Disease 01/2018
1	Hyperbilirubinemia 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Myocarditis (Carditis) 01/2017
1	Heart Diseases (Heart Disease) 10/2016
1	Left Ventricular Dysfunction 10/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2014
1	Hypertension (High Blood Pressure) 10/2014

Drug/Important Bio-Agent (IBA)

18	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 01/2002
11	Purinergic P1 Receptors (Adenosine Receptor)IBA 07/2013 - 01/2002
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2003
8	Adenosine Triphosphate (ATP)IBA 01/2009 - 05/2002
6	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2016 - 06/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2006
4	Insulin (Novolin)FDA Link 01/2022 - 01/2012
4	LipidsIBA 01/2022 - 01/2016
4	Phosphotransferases (Kinase)IBA 06/2021 - 05/2012
4	CholesterolIBA 01/2021 - 09/2014
4	Opioid Receptors (Opioid Receptor)IBA 01/2021 - 01/2011
3	LeptinIBA 09/2020 - 12/2018
3	CarbohydratesIBA 01/2020 - 03/2013
3	BilirubinIBA 01/2018 - 10/2014
3	Oxidants (Oxidizing Agents)IBA 11/2009 - 05/2005
3	Adenosine Diphosphate (ADP)IBA 12/2007 - 07/2002
3	2-Chloroadenosine (2 Chloroadenosine)IBA 01/2007 - 07/2002
3	1,3-dipropyl-8-cyclopentylxanthineIBA 01/2007 - 07/2002
2	CaveolinsIBA 09/2020 - 04/2020
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2018
2	Morphine (MS Contin)FDA LinkGeneric 09/2014 - 01/2011
2	LigandsIBA 09/2014 - 01/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013 - 02/2006
2	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2007 - 01/2002
2	Pyruvic Acid (Pyruvate)IBA 07/2006 - 03/2003
2	Complementary DNA (cDNA)IBA 02/2006 - 03/2003
2	chelerythrineIBA 06/2003 - 02/2003
2	mitochondrial K(ATP) channelIBA 02/2003 - 05/2002
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 09/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	Dynamins (Dynamin)IBA 01/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2020
1	Sucrose (Saccharose)IBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 12/2019
1	GhrelinIBA 12/2018
1	Caspase 3 (Caspase-3)IBA 05/2018
1	Pravastatin (Pravachol)FDA LinkGeneric 05/2018
1	EndocannabinoidsIBA 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2017
1	Ion Channels (Ion Channel)IBA 12/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Apelin ReceptorsIBA 01/2017
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	NeuregulinsIBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 10/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2016
1	AntioxidantsIBA 01/2016
1	Malondialdehyde (Propanedial)IBA 01/2016
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Testosterone (Sustanon)FDA Link 01/2016
1	Trenbolone AcetateIBA 01/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2016
1	Anti-Arrhythmia AgentsIBA 04/2015
1	HSP27 Heat-Shock ProteinsIBA 11/2013

Therapy/Procedure

3	Therapeutics 01/2017 - 04/2015
1	Injections 12/2019
1	Glycemic Control 05/2018
1	Contraindications 01/2016